Literature DB >> 31396342

HEY2 acting as a co-repressor with smad3 and smad4 interferes with the response of TGF-beta in hepatocellular carcinoma.

Jianqing Wang1, Bo Zhu1,2, Yuanyuan Zhang2, Hexige Saiyin2, Reziya Wumaier1, Long Yu2, Lichun Sun3, Qianyi Xiao1.   

Abstract

The HEY2 (hairy and enhancer of split-related with YRPW motif 2) is reported to play potential roles in tumorigenesis. However, the underlying mechanism in tumorigenesis is remain elusive. The present study aims to investigate the molecular mechanism of biological function of HEY2 in hepatocellular carcinoma (HCC). Dysfunction of the transforming growth factor-beta (TGF-β) pathway plays a critical role in HCC pathogenesis. Here, we identified HEY2 as a suppressor for TGF-β biological response. We demonstrated that HEY2 protein in tumor cytoplasm was up-regulated in HCC. Further, HEY2 overexpression inhibited TGF-β-induced growth arrest of HCC cells and inhibited TGF-β-induced downregulation of c-Myc, both in mRNA and in protein levels. While knockdown of HEY2, by small interfering RNA, was shown to enhance the TGF-β-mediated biological response of HCC cells. Moreover, HEY2 could form complexes with Smad3 and Smad4 and repress Smad3/Smad4 transcriptional activity. In conclusion, our findings indicate a novel role of HEY2 in mediating the TGF-β/Smad signaling pathway in HCC tumorigenesis.

Entities:  

Keywords:  HEY2; Smad; TGF-β; cell growth; hepatocellular carcinoma (HCC)

Year:  2019        PMID: 31396342      PMCID: PMC6684919     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  49 in total

1.  HRT1, HRT2, and HRT3: a new subclass of bHLH transcription factors marking specific cardiac, somitic, and pharyngeal arch segments.

Authors:  O Nakagawa; M Nakagawa; J A Richardson; E N Olson; D Srivastava
Journal:  Dev Biol       Date:  1999-12-01       Impact factor: 3.582

2.  Hey genes: a novel subfamily of hairy- and Enhancer of split related genes specifically expressed during mouse embryogenesis.

Authors:  C Leimeister; A Externbrink; B Klamt; M Gessler
Journal:  Mech Dev       Date:  1999-07       Impact factor: 1.882

Review 3.  Transcriptional control by the TGF-beta/Smad signaling system.

Authors:  J Massagué; D Wotton
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

Review 4.  TGFbeta signaling in growth control, cancer, and heritable disorders.

Authors:  J Massagué; S W Blain; R S Lo
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 5.  Transforming growth factor beta signaling mediators and modulators.

Authors:  C M Zimmerman; R W Padgett
Journal:  Gene       Date:  2000-05-16       Impact factor: 3.688

6.  Members of the HRT family of basic helix-loop-helix proteins act as transcriptional repressors downstream of Notch signaling.

Authors:  O Nakagawa; D G McFadden; M Nakagawa; H Yanagisawa; T Hu; D Srivastava; E N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

7.  Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway.

Authors:  B J Warner; S W Blain; J Seoane; J Massagué
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

8.  Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program.

Authors:  C R Chen; Y Kang; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

9.  A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest.

Authors:  G F Claassen; S R Hann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

10.  Characterization of the human and mouse HEY1, HEY2, and HEYL genes: cloning, mapping, and mutation screening of a new bHLH gene family.

Authors:  C Steidl; C Leimeister; B Klamt; M Maier; I Nanda; M Dixon; R Clarke; M Schmid; M Gessler
Journal:  Genomics       Date:  2000-06-01       Impact factor: 5.736

View more
  3 in total

1.  Partial-Methylated HeyL Promoter Predicts the Severe Illness in Egyptian COVID-19 Patients.

Authors:  Hewida H Fadel; Mohammad Abd El-Rahman Ahmed; Kareem Mahamoud Gharbeya; Mohammed Ahmed Khamis Mohamed; Mohamed N Roushdy; Reda Almiry
Journal:  Dis Markers       Date:  2022-05-31       Impact factor: 3.464

Review 2.  The Bright and the Dark Side of TGF-β Signaling in Hepatocellular Carcinoma: Mechanisms, Dysregulation, and Therapeutic Implications.

Authors:  Medine Zeynep Gungor; Merve Uysal; Serif Senturk
Journal:  Cancers (Basel)       Date:  2022-02-14       Impact factor: 6.639

3.  Pseudogene ACTBP2 increases blood-brain barrier permeability by promoting KHDRBS2 transcription through recruitment of KMT2D/WDR5 in Aβ1-42 microenvironment.

Authors:  Qianshuo Liu; Xiaobai Liu; Defeng Zhao; Xuelei Ruan; Rui Su; Xiuli Shang; Di Wang; Chunqing Yang; Yixue Xue
Journal:  Cell Death Discov       Date:  2021-06-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.